{"id":50421,"date":"2022-11-03T08:02:19","date_gmt":"2022-11-03T07:02:19","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/seven-pharma-ceos-announce-new-joint-action-to-accelerate-net-zero-healthcare\/"},"modified":"2022-11-03T08:02:19","modified_gmt":"2022-11-03T07:02:19","slug":"seven-pharma-ceos-announce-new-joint-action-to-accelerate-net-zero-healthcare","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/seven-pharma-ceos-announce-new-joint-action-to-accelerate-net-zero-healthcare\/","title":{"rendered":"Seven pharma CEOs announce new joint action to accelerate net zero healthcare"},"content":{"rendered":"
\n

\nAll seven global companies\u2019 near-term targets aligned to the 1.5<\/i>\u00b0C<\/i> pathway<\/i><\/b>\n<\/p>\n

\nEndorsement of commitments and action by health systems partners<\/i><\/b>\n<\/p>\n

LONDON–(BUSINESS WIRE)–#COP27<\/a>–CEOs from AstraZeneca, GSK, Merck KGaA, Novo Nordisk, Roche, Samsung Biologics and Sanofi today announced joint action to achieve near-term emissions reduction targets and accelerate the delivery of net zero health systems. For the first time, the global health sector has come together to reduce greenhouse gas emissions through the Sustainable Markets Initiative (SMI) Health Systems Task Force, a public-private partnership launched at COP26.\n<\/p>\n

<\/a><\/p>\n

\nThe Task Force is taking scalable action to collectively address emissions across supply chains, patient care pathways, and clinical trials. This includes aligning on a set of common supplier standards to incentivise decarbonisation efforts across the supply chain, and jointly pursuing renewable power purchase agreements and green transportation corridors. Task Force members will build an end-to-end care pathway emissions calculation standard and tool that allows stakeholders to measure and track emissions across the care pathway and will publish product-level life cycle assessments (LCA) data to increase transparency on treatment emissions. In addition, a common framework to measure the emissions from clinical trials will be created.\n<\/p>\n

\nThe connection between climate change and the health of humanity is proven and profound. Non-communicable and infectious diseases, malnutrition, threats to mental health and premature deaths are all increasing as a result of the climate crisis, with vulnerable populations most at risk. Air pollution causes seven million premature deaths globally each year1<\/sup> and extreme heat kills another 5 million annually.2,3<\/sup> Health systems are responding to the impacts of the climate crisis but are also responsible for 4-5% of total global net emissions, equating to 2.4 gigatonnes of carbon dioxide equivalent.4<\/sup>\n<\/p>\n

\nPascal Soriot, Chief Executive Officer, AstraZeneca, and Champion of the SMI Health Systems Task Force said: \u201cClimate change is the greatest global health threat of our time. During the pandemic, the healthcare sector stepped up and showed what can be achieved when we work together. Today, we act with the same urgency to tackle the climate crisis, with the collective commitments announced by the Sustainable Markets Initiative Health Systems Task Force setting a benchmark for others to drive action.\u201d\n<\/p>\n

\n\u201cThe case for decarbonising our health systems is clear, and failing to keep the 1.5\u00b0C goal alive will have irreversible impacts on global health,\u201d said Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization. \u201cTransitioning to low-carbon, climate-resilient health systems is essential for every country\u2019s journey towards universal health coverage. The commitments announced today demonstrate the power of public-private partnership to achieve positive and sustainable change for the health of people and the planet.\u201d\n<\/p>\n

\nToday, member companies of the Task Force unveiled their shared commitments to decarbonise at pace in three priority areas, which have been identified as drivers of the greatest positive impact in the sector: supply chains, patient care pathways, and clinical trials. Specific actions announced today include:\n<\/p>\n

\n1. Recognising that supply chain emissions drive over 50% of overall health care emissions, the Task Force members today announced they are committed to net zero emissions and will:\n<\/p>\n